Ferric Carboxymaltose Injection is an intravenous iron medicine used to treat iron deficiency and iron deficiency anemia when oral iron is unsuitable or insufficient.
Key Benefits
- Helps correct iron deficiency
- Supports treatment of iron deficiency anemia
- Helps replenish depleted body iron stores
- Supports normal hemoglobin and red blood cell production
- Useful when oral iron is not tolerated, ineffective, or clinically unsuitable
- Provides iron through intravenous administration under medical supervision
How It Works
Ferric carboxymaltose supplies iron that is gradually made available for use in the body. The iron supports hemoglobin production and replenishes iron stores, helping restore the amount of iron required for normal red blood cell formation and oxygen transport.
Common Side Effects
- Headache
- Dizziness
- Nausea
- Injection-site reactions
- Flushing
- Temporary changes in blood pressure
- Low phosphate levels
- Fatigue
Important Information
Ferric Carboxymaltose Injection should be administered intravenously by a qualified healthcare professional. Patients should be evaluated for iron deficiency before treatment, and iron status may require monitoring during therapy. Serious hypersensitivity reactions can occur, including during or shortly after administration, so appropriate observation is required. Repeated or high-dose treatment may cause low blood phosphate levels. Inform the healthcare professional about allergies, other medical conditions, and medicines being used.